Price Alert

Eton Pharmaceuticals Inc. (ETON)

NASDAQ: ETON · Real-Time Price · USD

17.15

0.45 (2.69%)

At close: Aug 15, 2025, 12:51 PM

Eton Pharmaceuticals Statistics

Share Statistics

Eton Pharmaceuticals has 26.82M shares outstanding. The number of shares has increased by 3.8% in one year.

Shares Outstanding	26.82M
Shares Change (YoY)	3.8%
Shares Change (QoQ)	0%
Owned by Institutions (%)	45.32%
Shares Floating	22.93M
Failed to Deliver (FTD) Shares	1,496
FTD / Avg. Volume	0.3%

Short Selling Information

The latest short interest is 3.05M, so 11.37% of the outstanding shares have been sold short.

Short Interest	3.05M
Short % of Shares Out	11.37%
Short % of Float	11.95%
Short Ratio (days to cover)	6.17

Valuation Ratios

The PE ratio is -90.22 and the forward PE ratio is 13.62. Eton Pharmaceuticals's PEG ratio is -0.29.

PE Ratio	-90.22
Forward PE	13.62
PS Ratio	8.84
Forward PS	4.1
PB Ratio	14.12
P/FCF Ratio	365.77
PEG Ratio	-0.29

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Eton Pharmaceuticals.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.06, with a Debt / Equity ratio of 1.22.

Current Ratio	2.06
Quick Ratio	1.29
Debt / Equity	1.22
Debt / EBITDA	-20.62
Debt / FCF	31.73
Interest Coverage	-1.3

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$1.26M
Profits Per Employee	$-123.32K
Employee Count	31
Asset Turnover	0.51
Inventory Turnover	1.02

Taxes

Income Tax	15K
Effective Tax Rate	-0.39%

Stock Price Statistics

The stock price has increased by 354.67% in the last 52 weeks. The beta is 1.14, so Eton Pharmaceuticals's price volatility has been higher than the market average.

Beta	1.14
52-Week Price Change	354.67%
50-Day Moving Average	15.06
200-Day Moving Average	14.22
Relative Strength Index (RSI)	69.1
Average Volume (20 Days)	504,759

Income Statement

In the last 12 months, Eton Pharmaceuticals had revenue of 39.01M and earned -3.82M in profits. Earnings per share was -0.15.

Revenue	39.01M
Gross Profit	23.41M
Operating Income	-2.6M
Net Income	-3.82M
EBITDA	-1.45M
EBIT	-2.6M
Earnings Per Share (EPS)	-0.15

Full Income Statement

Balance Sheet

The company has 14.94M in cash and 29.92M in debt, giving a net cash position of -14.98M.

Cash & Cash Equivalents	14.94M
Total Debt	29.92M
Net Cash	-14.98M
Retained Earnings	-107.89M
Total Assets	84.03M
Working Capital	24.61M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 969K and capital expenditures -26K, giving a free cash flow of 943K.

Operating Cash Flow	969K
Capital Expenditures	-26K
Free Cash Flow	943K
FCF Per Share	0.04

Full Cash Flow Statement

Margins

Gross margin is 60.01%, with operating and profit margins of -6.66% and -9.8%.

Gross Margin	60.01%
Operating Margin	-6.66%
Pretax Margin	-9.76%
Profit Margin	-9.8%
EBITDA Margin	-3.72%
EBIT Margin	-6.66%
FCF Margin	2.42%

Dividends & Yields

ETON does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for ETON is $28, which is 64.2% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$28
Price Target Difference	64.2%
Analyst Consensus	Strong Buy
Analyst Count	3

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	3.13
Piotroski F-Score	3